RIOFY
Live / Allowed — Published for opposition (as of 21 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99027161
- Mark type
- Stylized text
- Filed
- 03 Feb 2025
- Published for opposition
- 21 Jul 2026
- Attorney of record
- Hun Joon Kim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, and auto-immune disease; Biotechnological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, and auto-immune disease; Biological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, and auto-immune disease; Medicines for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, and auto-immune disease; Pharmaceuticals for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, and auto-immune disease
Owner
- CMG Pharmaceutical CO., LTD., Seoul, KR
- CMG Pharmaceutical CO., LTD., Seoul, KR
Prosecution history
- 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jul 2026 — PUBLISHED FOR OPPOSITION
- 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Jun 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 06 May 2026 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 06 May 2026 — INQUIRY TO SUSPENSION E-MAILED
- 06 May 2026 — SUSPENSION INQUIRY WRITTEN
- 01 May 2026 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 26 Aug 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 26 Aug 2025 — LETTER OF SUSPENSION E-MAILED